OTLY Q1 2026 Earnings BetterThanExpected Loss Marks Progress but Revenue Details Remain Unclear FSEA Q3 2024 Earnings Modest Profit Amid Narrowing Margins Ferrovial Q4 2025 Earnings EPS Beats Estimates by 526 Despite Stock Decline Centessa Pharmaceuticals CNTA Q1 2026 Earnings EPS Miss Amid PreRevenue Phase Stock Slips Slightly SGU Q1 2026 Earnings Strong Seasonal EPS Contributes to Solid Start Stock Slips MCRI Q1 2026 Earnings EPS Surges Past Estimates by 349